OTC Pharmaceuticals - South Korea

  • South Korea
  • The OTC Pharmaceuticals market in South Korea is set to reach a revenue of ₩US$4.84bn in 2024.
  • This market is projected to experience an annual growth rate of 4.60% (CAGR 2024-2029).
  • Among the various submarkets, the largest market is Other OTC Pharmaceuticals, which is expected to have a market volume of ₩US$1.39bn in 2024.
  • When compared globally, the in the United States leads in revenue generation, with an estimated ₩US$41,240.00m in 2024.
  • In terms of per capita revenue, in South Korea is expected to generate ₩US$93.52 per person in 2024.
  • Furthermore, online sales are predicted to contribute 0.00% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • South Korea's OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies due to the country's rich cultural heritage and belief in natural healing methods.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in South Korea has been experiencing steady growth in recent years.

Customer preferences:
South Korean consumers have shown a growing preference for self-medication and over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including increasing healthcare costs, busy lifestyles, and a desire for convenience. Consumers are increasingly relying on OTC medications to treat common ailments and minor health issues, such as headaches, colds, and allergies. They appreciate the accessibility and ease of purchasing these products without the need for a prescription.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in South Korea is the growing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more natural. This has led to an increase in the availability and popularity of herbal supplements and traditional Korean medicine products. Manufacturers are responding to this trend by introducing new OTC products that cater to the demand for natural remedies.Another trend in the market is the increasing popularity of online retail channels for purchasing OTC pharmaceuticals. South Korea has a high internet penetration rate and consumers are increasingly turning to online platforms to buy healthcare products, including OTC medications. Online retail offers convenience, competitive pricing, and a wide range of products, making it an attractive option for consumers. This trend has prompted both traditional brick-and-mortar retailers and online pharmacies to expand their online presence and offer a seamless shopping experience for OTC pharmaceuticals.

Local special circumstances:
South Korea has a well-established healthcare system that provides universal coverage and access to prescription medications. However, the government has been taking steps to encourage self-medication and reduce the burden on the healthcare system. This includes promoting the use of OTC medications for common ailments and minor health issues. The government has also implemented regulations to ensure the safety and quality of OTC pharmaceutical products, which has further boosted consumer confidence in these products.

Underlying macroeconomic factors:
South Korea has a strong economy and a high standard of living, which has contributed to the growth of the OTC Pharmaceuticals market. Increasing disposable incomes have allowed consumers to spend more on healthcare products, including OTC medications. Additionally, the aging population in South Korea has led to a higher demand for healthcare products and services, including OTC pharmaceuticals. As the population continues to age, the demand for OTC medications is expected to further increase.In conclusion, the OTC Pharmaceuticals market in South Korea is experiencing steady growth due to changing customer preferences, including a preference for self-medication and natural remedies. The increasing popularity of online retail channels and the government's efforts to promote self-medication have also contributed to the market's growth. With a strong economy and an aging population, the demand for OTC medications is expected to continue to rise in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)